A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2025

Study Completion Date

November 30, 2025

Conditions
Low Grade Glioma
Interventions
DRUG

Carboplatin and Vincristine

Carboplatin 175 mg/m2 IV infusion Vincristine 1.5mg/m2 IV

DRUG

Carboplatin

Carboplatin 560 mg/m2 (or 19 mg/kg for children weighing less than 12 kg) IV

Trial Locations (21)

21287

The Johns Hopkins Hospital, Baltimore

32806

Orlando Health, Inc., Orlando

43205

Nationwide Children's Hospital, Columbus

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

46260

St. Vincent Peyton Manning Children's Hospital, Indianapolis

52242

University of Iowa, Iowa City

53226

Medical College of Wiscosin, Milwaukee

53792

American Family Children's Hospital, Madison

55404

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis

60611

Ann & Robert H. Lurie Children's Hosptial of Chicago, Chicago

85016

Phoenix Children's Hospital, Phoenix

92123

Rady Children's Hospital, San Diego

06520

Yale University, New Haven

02115

Dana-Farber Cancer Institute, Boston

48109-5652

University of Michigan, C.S. Mott Children's Hospital, Ann Arbor

63103-2006

Saint Louis University at SSM Cardinal Glennon Children's Medical Center, St Louis

63110-1010

Washington University School of Medicine, St Louis

12208-3479

Albany Medical Center, Albany

27705-4682

Duke University Medical School, Durham

44308-1062

Children's Hospital Medical Center of Akron, Akron

45404-1815

Dayton Children's Hospital, Dayton

All Listed Sponsors
lead

Alicia Lenzen

OTHER